- Record: found
- Abstract: not found
- Article: not found
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
Guillermo Garcia-Manero ,
Pierre Fenaux ,
Aref Al-Kali ,
Maria R Baer ,
Mikkael A Sekeres ,
Gail J Roboz ,
Gianluca Gaidano ,
Bart L Scott ,
Peter Greenberg ,
Uwe Platzbecker ,
David P Steensma ,
Suman Kambhampati ,
Karl-Anton Kreuzer ,
Lucy A Godley ,
Ehab Atallah ,
Robert Collins ,
Hagop Kantarjian ,
Elias Jabbour ,
Francois E Wilhelm ,
Nozar Azarnia ,
Lewis R Silverman
April 2016
April 2016
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.